We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+28.06%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$8.28B
AUM Growth
+$544M
Cap. Flow
-$651M
Cap. Flow %
-7.87%
Top 10 Hldgs %
64.5%
Holding
301
New
80
Increased
38
Reduced
62
Closed
67

Top Buys

Rank Stock Value
1
WORK
Slack Technologies, Inc.
WORK
+$612M
2
XLNX
Xilinx Inc
XLNX
+$523M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$380M
4
INFO
IHS Markit Ltd. Common Shares
INFO
+$271M
5
IPHI
INPHI CORPORATION
IPHI
+$171M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$448M
2
IMMU
Immunomedics Inc
IMMU
+$333M
3
TCO
Taubman Centers Inc.
TCO
+$167M
4
PCG icon
PG&E
PCG
+$160M
5
AMTD
TD Ameritrade Holding Corp
AMTD
+$159M

Sector Composition

Rank Sector Weight
1 Technology 11.92%
2 Healthcare 7.46%
3 Materials 5.96%
4 Communication Services 4.33%
5 Industrials 4.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PRVL
201
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$408K ﹤0.01%
+17,694
New +$224K
GMAB icon
202
Genmab
GMAB
$19.5B
$407K ﹤0.01%
10,000
– –
MSP
203
DELISTED
Datto Holding Corp.
MSP
$405K ﹤0.01%
+15,000
New +$425K
NTST
204
NETSTREIT Corp
NTST
$2.1B
$390K ﹤0.01%
20,000
-23,205
-54% -$429K
MRNA icon
205
Moderna
MRNA
$23.6B
$366K ﹤0.01%
3,500
-15,000
-81% -$1.52M
LESL icon
206
Leslie's
LESL
$11M
$347K ﹤0.01%
+625
New +$281K
ORIC icon
207
Oric Pharmaceuticals
ORIC
$1.4B
$339K ﹤0.01%
10,000
+2,000
+25% +$57.4K
ADCT icon
208
ADC Therapeutics
ADCT
$144M
$320K ﹤0.01%
10,000
– –
AAL icon
209
CALL
American Airlines Group
AAL
$10.6B
$315K ﹤0.01%
20,000
-698,500
-97% -$9.68M
GAN
210
DELISTED
GAN Ltd
GAN
$304K ﹤0.01%
+15,000
New +$251K
PTON icon
211
Peloton Interactive
PTON
$2.49B
$303K ﹤0.01%
+2,000
New +$244K
ALGM icon
212
Allegro MicroSystems
ALGM
$8.16B
$280K ﹤0.01%
+10,521
New +$254K
LYRA
213
DELISTED
LYRA THERAPEUTICS INC
LYRA
$271K ﹤0.01%
476
– –
ALLO icon
214
Allogene Therapeutics
ALLO
$694M
$252K ﹤0.01%
10,000
– –
AJRD
215
DELISTED
Aerojet Rocketdyne Holdings
AJRD
$238K ﹤0.01%
+4,500
New +$181K
LUV icon
216
Southwest Airlines
LUV
$23B
$233K ﹤0.01%
+5,000
New +$217K
CCC
217
CCC Intelligent Solutions
CCC
$4.08B
$228K ﹤0.01%
+20,000
New +$243K
SILK
218
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$220K ﹤0.01%
3,500
-1,500
-30% -$93.1K
VSTA
219
DELISTED
Vasta Platform
VSTA
$218K ﹤0.01%
15,000
– –
BCYC
220
Bicycle Therapeutics
BCYC
$292M
$215K ﹤0.01%
12,000
– –
OZON
221
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
$207K ﹤0.01%
+5,000
New +$218K
VIAO
222
DELISTED
VIA optronics AG American Depositary Shares, each representing one-fifth of an Ordinary Share
VIAO
$201K ﹤0.01%
14,900
– –
RAPT
223
PUT
DELISTED
RAPT Therapeutics
RAPT
$198K ﹤0.01%
+1,250
New +$272K
BIOR
224
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$197K ﹤0.01%
148
-12
-8% -$17.6K
TBIO
225
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$184K ﹤0.01%
10,000
-5,000
-33% -$89.5K
7 8
9
10 11

Similar funds

CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

Pentwater Capital Management's Q4 2020 Portfolio in Review

As of Q4 2020, Pentwater Capital Management held 301 positions worth $8.28B, up 7% from $7.73B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Pentwater Capital Management withdrew a net $651M in Q4 2020, closing 67 positions and reducing 62 holdings. Its most notable exit was Immunomedics Inc, an estimated $333M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Materials.

Against the trend, Pentwater Capital Management opened a new position in Slack Technologies, Inc. worth $765M.

  • Pentwater Capital Management's largest Q4 2020 buy was Slack Technologies, Inc.: 18,106,000 shares worth $765M.
  • Pentwater Capital Management added most to Maxim Integrated Products in Q4 2020, an estimated $150M increase.
  • Pentwater Capital Management's biggest Q4 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $448M.
  • Pentwater Capital Management fully exited Immunomedics Inc in Q4 2020, selling an estimated $333M.
  • Pentwater Capital Management's ten largest holdings make up 64% of its $8.28B portfolio in Q4 2020.
  • Pentwater Capital Management opened 80 new positions and closed 67 in Q4 2020.
  • Pentwater Capital Management's portfolio value rose 7% quarter-over-quarter to $8.28B.

Based on Pentwater Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.